Coronary Angiography Devices Market Outlook Signals Expansion To $13.82 Billion Through 2030

The coronary angiography devices market is set to experience significant growth in the coming years, driven by advances in medical technology and increasing healthcare needs. This sector is crucial for diagnosing and treating heart conditions, and ongoing innovations are expected to further enhance its scope and effectiveness. Let's explore the market size projections, key players, emerging trends, and detailed segmentation shaping the future of coronary angiography devices.

Forecasted Expansion and Market Size of Coronary Angiography Devices
The coronary angiography devices market is projected to reach a valuation of $13.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6%. Several factors contribute to this uptrend, including an aging population with elevated cardiovascular risks, growing demand for timely and accurate coronary diagnostics, the proliferation of interventional cardiology centers, increased adoption of image-guided cardiac procedures, and a stronger emphasis on preventive cardiovascular care. Key trends influencing the market include a shift toward minimally invasive diagnostic techniques, wider use of advanced imaging technologies, rising demand for precise coronary visualization, expanded applications of angiography in early cardiac disease detection, and the integration of diagnostic and therapeutic angiography workflows.

Download a free sample of the coronary angiography devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18800&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Factors Fueling Growth in the Coronary Angiography Devices Market
One major driver behind the market's expansion is the rising prevalence of cardiovascular diseases linked to aging populations, which elevates the need for effective diagnostic tools. Accurate and early detection through coronary angiography helps improve patient outcomes and optimize treatment plans.
Moreover, the increasing adoption of minimally invasive and image-guided procedures enhances procedural safety and precision, encouraging hospitals and clinics to invest more in these technologies. The growing number of interventional cardiology centers worldwide is also boosting demand, as these facilities require sophisticated devices to perform complex cardiac interventions.

Top Companies Leading the Coronary Angiography Devices Industry
The coronary angiography devices market features several dominant players, including Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., and Alvimedica.

View the full coronary angiography devices market report:
https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Noteworthy Corporate Moves in Coronary Angiography Devices
In April 2023, Abbott, a US-based medical device manufacturer, acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition aligns with Abbott's strategy to broaden its cardiovascular portfolio, particularly focusing on interventional therapies for peripheral and coronary artery diseases. By incorporating Cardiovascular Systems' innovative technologies and expertise, Abbott aims to strengthen its cardiovascular care offerings. Cardiovascular Systems, Inc. is known for developing and marketing products targeting coronary and peripheral vascular diseases.

Emerging Technological Trends in the Coronary Angiography Devices Market
Leading companies in this market are prioritizing the development of next-generation drug-eluting stents designed to improve procedural accuracy, patient outcomes, and long-term heart health. These stents feature enhanced scaffolding, advanced drug coatings, and improved delivery mechanisms to minimize restenosis and support arterial healing.
For example, in May 2024, Abbott Laboratories introduced its XIENCE Sierra stent in India. This device offers cardiologists greater flexibility, precise deployment, and enhanced safety features. The launch aims to expand treatment options and elevate the standard of care for coronary artery disease. By combining cutting-edge design with clinical insights, the XIENCE Sierra supports improved procedural efficiency and patient-centered results, reinforcing Abbott's commitment to innovation in cardiovascular medicine.

Detailed Segmentation of the Coronary Angiography Devices Market
This market is segmented into multiple categories to capture the diverse product types, technologies, indications, applications, and end-users:
1) By Product Type: Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, Angiography Accessories
2) By Technology: X-Ray Angiography, Computed Tomography Angiography (CTA), Magnetic Resonance Angiography, Other Technologies
3) By Indication: Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Other Indications
4) By Application: Diagnostics, Therapeutics
5) By End-User: Hospitals and Clinics, Diagnostic and Imaging Centers, Research Institutes

Further Subcategories within Product Types
Within angiography systems, the market includes X-Ray Angiography Systems, 3D or 4D Angiography Systems, and Digital Subtraction Angiography (DSA) Systems.
Angiography catheters are broken down into diagnostic catheters, therapeutic catheters, over-the-wire (OTW) catheters, and rapid exchange (RX) catheters.
Contrast media is classified as iodinated and non-iodinated options.
Vascular closure devices are categorized into mechanical, passive hemostasis, and active hemostasis devices.
Angiography balloons include high-pressure, low-pressure, and drug-eluting balloons.
Guidewires are segmented into standard, supportive, and steerable guidewires.
Accessories encompass introducer sheaths, inflation devices, syringes and needles, and guidewire support systems.

This comprehensive segmentation offers a clear understanding of the coronary angiography devices market's complexity and the variety of products and technologies shaping its evolution.

New analytical features added to our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.